Skip to main content

Table 1 General patients characteristics

From: High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

Factor

N (%)

Number of patients

11

Age (median)

18–62 (40) years

Gender

 

F

6 (55 %)

M

5 (45 %)

SS-m

6 (55 %)

MS

5 (45 %)

Risk organ involvement

5 (45 %)

Lung

4 (36 %)

Spleen

1 (9 %)

Prior therapy

2 (18 %)

Radiotherapy

1 (9 %)

Topical steroids

1 (9 %)

  1. N number, F female, M male, SS-m single system multifocal, MS multisystem
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us